PMID: 2491420Sep 22, 1989Paper

Methadone treatment and acquired immunodeficiency syndrome

JAMA : the Journal of the American Medical Association
J R Cooper

Abstract

In light of the recent growth in public financial support for the rapid expansion of drug abuse treatment capacity, the unique effectiveness of methadone hydrochloride treatment in reducing intravenous opioid abuse and the associated sharing of injection equipment is reviewed and discussed, and its potential effect on preventing the spread of acquired immunodeficiency syndrome is examined. In addition to methadone, treatment variables that clinical research suggests are integral to effective treatment are identified. Methadone treatment is one of the most helpful means of reducing the risk of acquired immunodeficiency syndrome available, provided that programs of quality are expanded. The medical profession and universities are urged to take steps to ensure quality effort in prevention and treatment.

Citations

Oct 1, 1991·American Journal of Public Health·P A Selwyn
Mar 3, 1990·BMJ : British Medical Journal·J Greenwood
Jan 1, 1995·American Journal of Public Health·H A SiegalJ Wang
Sep 10, 1994·BMJ : British Medical Journal·P WilsonG E Ralston
Feb 1, 1994·American Journal of Public Health·A Umbricht-SchneiterG E Bigelow
Jul 18, 2000·American Journal of Public Health·G S ZaricM L Brandeau
Jun 1, 2006·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Scott S SantibanezAlan E Greenberg
Oct 31, 2009·The American Journal on Addictions·Shannon Gwin MitchellRobert P Schwartz
Aug 11, 2015·Addictive Behaviors·Stacey C SigmonRobert P Schwartz
Dec 19, 2006·Journal of Substance Abuse Treatment·Nancy D Berkman, Wendee M Wechsberg
Aug 1, 1992·Drug and Alcohol Dependence·N Loimer, R Schmid
Jun 24, 2006·Drug and Alcohol Dependence·Robert P SchwartzKevin E O'Grady
May 6, 2006·Drug and Alcohol Dependence·Donna M CovielloArthur I Alterman
May 6, 2015·Preventive Medicine·Stacey C Sigmon
May 24, 2000·Drug and Alcohol Dependence·P P PaniG L Gessa
Jan 1, 1992·The American Journal of Drug and Alcohol Abuse·J F Maddux, D P Desmond
Jan 1, 1993·The American Journal of Drug and Alcohol Abuse·W S Condelli, G H Dunteman
Oct 17, 1998·Psychological Reports·J B Murray
Nov 1, 1992·Journal of Clinical Psychology·M A Gentile, J B Milby
Jan 1, 1995·European Archives of Psychiatry and Clinical Neuroscience·G Bertschy
Jan 1, 1996·Psychopharmacology·K L PrestonG E Bigelow
Feb 1, 1995·The American Journal of Drug and Alcohol Abuse·R G Newman
Feb 1, 1995·The American Journal of Drug and Alcohol Abuse·J McCuskerB F Lewis
Dec 3, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·M-J MilloyEvan Wood
Apr 1, 1991·Journal of Psychoactive Drugs·J MartinJ E Zweben

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Epidemiology
A M PattiG M Fara
Archives of Internal Medicine
V P Dole, M E Nyswander
The International Journal of the Addictions
E C Senay
© 2022 Meta ULC. All rights reserved